Sandu Pharmaceuticals Share Price
SANDUPHQ
Live Sandu Pharmaceuticals Share Price Chart
Sandu Pharmaceuticals Performance
Days Range
| Previous Close | ₹39.80 |
|---|---|
| Open | ₹40.35 |
| Volume | 1,463 |
| Day's Range | ₹38.50 - ₹40.39 |
|---|---|
| 52W Range | ₹30.00 - ₹58.28 |
| Market Cap | ₹38.45 Cr |
Sandu Pharmaceuticals Fundamentals
| ROCE(TTM) | 5.32 |
|---|---|
| P/E Ratio (TTM) | 24.72 |
| P/B Ratio | 1.15 |
| Industry P/E | 37.01 |
| Debt to Equity | 0.01 |
| ROE | 3.69 |
| EPS (TTM) | 1.61 |
| Dividend Yield | 2.01 |
| Book Value | 34.63 |
| Face Value | 10 |
| ROCE(TTM) | 5.32 |
|---|---|
| P/E Ratio (TTM) | 24.72 |
| P/B Ratio | 1.15 |
| Industry P/E | 37.01 |
| Debt to Equity | 0.01 |
| ROE | 3.69 |
|---|---|
| EPS (TTM) | 1.61 |
| Dividend Yield | 2.01 |
| Book Value | 34.63 |
| Face Value | 10 |
Sandu Pharmaceuticals Financials
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | |
|---|---|---|---|---|
| Net Sales | 17.05 | 17.70 | 18.37 | 14.07 |
| Expenses | 16.80 | 16.97 | 17.57 | 13.77 |
| Profit before tax | 0.27 | 0.74 | 0.80 | 0.34 |
| Operating Profit | 0.17 | 0.50 | 0.56 | 0.33 |
| Net Profit | 0.17 | 0.50 | 0.56 | 0.33 |
| EPS in Rs | 0.17 | 1.95 | 0.57 | 0.34 |
Sandu Pharmaceuticals Shareholding Pattern
Promoters
37.79%
Retail And Others
62.21%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.01%
About Sandu Pharmaceuticals
Sandu Pharmaceutical (SPL) was established in 1985 and manufactures ayurvedic medicines with its plant located at Chembur in Bombay. The company markets 30 different ayurvedic products. Bhaskar Sandu is the chairman. Its other manufacturing unit is located at Pilerne Industrial Estate in Goa.
SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations. This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards. Ayurvedic products have a very good market in India and abroad due to their minimal side effects.
The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
Parent Organisation
Indian Private
Managing Director
Balaram Vishwanathan
Founded
1985
NSE Symbol
Top Mutual Funds Invested in Sandu Pharmaceuticals Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,942.0 -2.40 (-0.12%) | ₹4,68,530.14 | 1,548.0 - 2,046.9 |
| Divis Laboratories Ltd | 8,560.0 260.00 (3.13%) | ₹2,19,675.25 | 5,636.5 - 8,585.0 |
| Torrent Pharmaceuticals Ltd | 4,883.0 -41.00 (-0.83%) | ₹1,86,969.82 | 3,480.6 - 5,250.0 |
| Cipla Ltd | 1,463.0 -4.70 (-0.32%) | ₹1,17,945.42 | 1,165.7 - 1,673.0 |
| Zydus Lifesciences Ltd | 1,194.3 75.30 (6.73%) | ₹1,11,790.25 | 835.5 - 1,205.0 |
| Lupin Ltd | 2,278.9 -21.10 (-0.92%) | ₹1,04,020.40 | 1,875.0 - 2,529.5 |
Popular Stocks
Sandu Pharmaceuticals Ltd FAQs
Can I buy Sandu Pharmaceuticals Ltd (Sandu Pharmaceuticals Ltd) from Angel One?
Yes, You can buy Sandu Pharmaceuticals Ltd (Sandu Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
How do I buy Sandu Pharmaceuticals Ltd (Sandu Pharmaceuticals Ltd) from Angel One?
Sandu Pharmaceuticals Ltd (Sandu Pharmaceuticals Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Sandu Pharmaceuticals Ltd (Sandu Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Sandu Pharmaceuticals Ltd (Sandu Pharmaceuticals Ltd) shares.
1. Direct investment: You can buy Sandu Pharmaceuticals Ltd (Sandu Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Sandu Pharmaceuticals Ltd (Sandu Pharmaceuticals Ltd) shares.
